Loading...
No images? Click here Thursday, 9 March 2023 MEDIA ADVISORY Integrating Research into Outbreaks: How can we prepare for the next Marburg outbreak?10 March 2023 - 1400 CET The WHO R&D Blueprint is organizing a consultation with the MARVAC partners and focal points from at-risk countries to discuss Marburg vaccine and therapeutic candidates and integrating research during an outbreak. Preliminary Agenda
The MARVAC includes leaders in the field of vaccine research and development, working together to develop vaccines against this infectious disease threat. This is an open webinar. Registration link for non-MARVAC members: https://who-e.zoom.us/webinar/register/WN_ETAht7eETMStDmUah5mDaA
Resources Marburg virus disease (who.int)Press release: Equatorial Guinea confirms first-ever Marburg virus disease outbreak https://www.afro.who.int/countries/equatorial-guinea/news/equatorial-guinea-confirms-first-ever-marburg-virus-disease-outbreakLandscape of candidate vaccines for Marburg virus disease https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010805Current progress, challenges, and future directions for Marburg virus disease vaccines https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679315/R&D Blueprint agenda for filovirus research and monitoring https://www.who.int/publications/m/item/a-who-strategic-research-agenda-for-filovirus-research-and-monitoring-----(who-afirm)R&D Blueprint for Ebolavirus and Marburg https://www.who.int/teams/blueprint/ebolavirusMarburg virus disease factsheet https://www.who.int/news-room/fact-sheets/detail/marburg-virus-disease
Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list.
|
Loading...
Loading...